| Literature DB >> 35056690 |
Rabia Ikram1, Shamsul Azlin Ahmad Shamsuddin2, Badrul Mohamed Jan1, Muhammad Abdul Qadir3, George Kenanakis4, Minas M Stylianakis4,5, Spiros H Anastasiadis4.
Abstract
Thanks to stem cells' capability to differentiate into multiple cell types, damaged human tissues and organs can be rapidly well-repaired. Therefore, their applicability in the emerging field of regenerative medicine can be further expanded, serving as a promising multifunctional tool for tissue engineering, treatments for various diseases, and other biomedical applications as well. However, the differentiation and survival of the stem cells into specific lineages is crucial to be exclusively controlled. In this frame, growth factors and chemical agents are utilized to stimulate and adjust proliferation and differentiation of the stem cells, although challenges related with degradation, side effects, and high cost should be overcome. Owing to their unique physicochemical and biological properties, graphene-based nanomaterials have been widely used as scaffolds to manipulate stem cell growth and differentiation potential. Herein, we provide the most recent research progress in mesenchymal stem cells (MSCs) growth, differentiation and function utilizing graphene derivatives as extracellular scaffolds. The interaction of graphene derivatives in human and rat MSCs has been also evaluated. Graphene-based nanomaterials are biocompatible, exhibiting a great potential applicability in stem-cell-mediated regenerative medicine as they may promote the behaviour control of the stem cells. Finally, the challenges, prospects and future trends in the field are discussed.Entities:
Keywords: graphene oxide; mesenchymal stem cells; nanotechnology; tissue engineering
Mesh:
Year: 2022 PMID: 35056690 PMCID: PMC8781794 DOI: 10.3390/molecules27020379
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1MSCs differentiation types and growth factors of various cell types. Illustration of ECM proteins at various stages [41].
Figure 2Selective nanomaterials and stem cell growth. (A) Potential carbon allotropes for stem cell differentiation and growth, (B) the effect of graphene and GO on stem cell growth, proliferation, and tissue lineages [10].
Figure 3Schematic representation of GO as a competent drug nanocarrier on MSCs for cancer therapy [74].
Figure 4The effects of GO based drug delivery systems on MSCs: (A) The function of three different toxicity models, (B) the assessment of cancer cell (LN18) viability upon the loading of two different drugs in various amounts, (C) cancer cell (LN18) toxicity evaluation of the three models presented in (A) (where n = 3; significance: ** p < 0.01; n.s.: not significant; determined by One-way ANOVA) [74].
Figure 5MSCs proliferation using SF/GO composites in different ratios, i.e., SF/0.05% GO, SF/0.1 %GO, and SF/0.2% GO. Proliferation rate was indirectly estimated by the absorbance as a function of time (** p < 0.05, * p < 0.01) [98].
Figure 6Size effects on human adipose-derived MSCs using micro and nano-sized GO substrates presenting enhanced proliferation rates of 100, 250 and 500 μg/mL (A) 2 days of proliferation, (B) cell population and (C) proliferated cell areas after 2 days of proliferation (* p < 0.05, n = 3; navy: MGO, gray: NGO) [111].
Exposure of various cell types to graphene derivatives in different conditions.
| Graphene-Based Nanomaterials (Exposure Conditions) | Cell Types | Effects | Ref. |
|---|---|---|---|
| GO [50 µg/mL for 24 h] | Human fibroblast cells | Dose and time dependent cytotoxicity, causes cell floating and apoptosis | [ |
| GO [1–100 µg/mL for 24 h] | Human | Impact on cellular generation and promotion of Reactive oxidative stress (ROS) | [ |
| GO [50 µg/mL for 24 h] | Mouse embryonic fibroblasts | Higher degree of cytotoxicity and apoptosis | [ |
| Carboxyl Graphene nanoplates [4 μg/mL for 24 h] | Human liver carcinoma cell (HepG2) | High cytotoxicity and induction of ROS | [ |
| rGO [50 μg/mL for 24 h] | HepG2 | High cytotoxicity and induction of ROS | [ |
Figure 7Human MSCs interactions with numerous types of microgels, i.e., Alginate, GO/Alg, rGO/Alg (1 h) and rGO/Alg (3 h). (A) Screening of stains at various H2O2 concentrations, (B) the microgels’ percentage content incubated in MCSc using different H2O2 concentrations, where existed a remarkable transformation (* p < 0.05) [124].
Figure 8The ALP assay was performed in cells cultivated for 7 and 14 days. No significant differences were observed after 7 days, although remarkable differences were shown after 14 days when GS1 and GS2 exhibited enhanced ALP activity, while GS3 containing 1 μM of Simvastatin presented a lower level of ALP. Error bars represent +/− standard deviations (n ≥ 3). *** p < 0.001 [139].
Figure 9GO coatings on Ti substrate display significant biocompatibility. In osteogenic activity, GO coatings enhance osteogenic genes, osteoinductive ability and extracellular matrix mineralization of the MSCs, while GO normalizes polarization through receptors which stimulate cytokines and thus improve osteogenic differentiation [154].
Effects of various NPs on Rat Bone Marrow MSCs.
| NPs | Effects on Rat Bone Marrow MSCs | Ref. |
|---|---|---|
| Gold | Efficient coating for gene delivery to MSCs with antibacterial activity | [ |
| Calcium phosphate ceramic | Commonly applied in bone tissue engineering to present higher cell viability and cell adhesion | [ |
| Gelatine-based hydrogels | Enhancement of rat neonatal cardiomyocyte adhesion and stimulate maturation | [ |
| Poly-L-lactide (PLLA) scaffold | From thermal-induced phase separation techniques to enhance the regeneration of bone marrow MSCs and to increase calcium deposition | [ |
| Self-supporting graphene hydrogel (SGH) | Implanted into subcutaneous sites of rats leading to the formation of new blood vessels stimulating osteogenic differentiation | [ |
| Magnetic GO | Exhibited a significant increase in bone formation related genes such as β-catenin, Runx2, BMP-2, and OCN | [ |
| Titanium | Tends to release BMP2 differentiation inducing proteins to increase osteogenic in vitro and in vivo differentiation | [ |
| Aluminium oxide | Hippocampal cells were subjected to severe toxicity and apoptosis. Adipose-derived MSCs suppressed oxidative stress and stimulated immunity, as well as alleviated toxicity of Al2O3 via the regulation of P53, Aβ, SOX2, OCT4, and CYP2E1 signalling in hippocampal cells | [ |
| Selenium | The combination of Se NPs and stem cells greatly reduced Aβ deposition while the concentration of brain derived neurotrophic factor (BDNF) was increased. Accordingly, excellent results in neuroprotection of Alzheimer’s disease were obtained | [ |
Summary of GO based nanomaterials in MSCs.
| Nanomaterials | Parameters | Outcomes | Applications | Ref. |
|---|---|---|---|---|
| GO/alginate | Addition of 0.05 to 1.0 mg mL−1 GO to 3% alginate | 3D scaffolds printed with MSCs and alginate/GO greatly improved osteogenic differentiation | Bone regeneration | [ |
| Graphene |
No evidence of cytotoxicity in stem cell cultures Promoted cardiomyogenic differentiation | Stem cell engineering | [ | |
| GO/alginate | 2 mg/mL of GO and 20 mg/mL of alginate |
Based on in vitro studies, MSCs viability increased under oxidative stress conditions with H2O2 In vivo studies also revealed enhanced therapeutic efficacy of MSCs delivery in r(GO/alginate) microgels | Tissue regeneration | [ |
| GO | Drug-GO complex loaded on MSCs demonstrated selective killing of cancer cells without affecting the MSCs viability | Platform for drug delivery | [ | |
| Graphene nano-onions (GNOs, GONRs, and GONPs) | Concentrations ranging from 5 to 300 µg/mL |
There were no significant differences in cytotoxicity between graphene nanostructures with less than 50 µg/mL concentrations and untreated controls Low (10 µg/mL) or high (50 µg/mL) graphene concentrations had no effect on adipogenic and osteogenic differentiation potential of MSCs | MSCs-based imaging and therapy | [ |
| Graphene-incorporated chitosan substrate | 0, 0.05, 0.5, and 5% | Promoted adhesion and human MSCs differentiation | Tissue engineering | [ |
| GO incorporated cellulose acetate (CA) | 0 to 1 wt.% of GO | Biomineralization and human MSCs osteogenic differentiation were improved significantly | Bone tissue engineering and regenerative medicine | [ |
| GO-calcium phosphate | 0.5 μg mL−1 GO and 10 μg mL−1 calcium phosphate | Synergistic osteoinductive effect on human MSCs | Bone tissue engineering and regenerative medicine | [ |
| Graphene-based nanomaterials |
Boosted the effective dose of MSCs-Exos at local wound sites. Enabled MSCs-Exos to achieve improved long-term acting time, retention rate, and stability | Tissue engineering | [ | |
| GO | The use of peptide and protein-GO conjugates: Stem cell growth Increases cytocompatibility Transmits chemical signals that promote MSCs differentiation through a specific pathway | Tissue engineering | [ | |
| Cross-linked polyethylenimine (PEI) grafted GO | Neuronal differentiation of MSCs with function was significantly accelerated both in vitro and in vivo | Regenerative therapy | [ | |
| Graphene/polycaprolactone scaffolds | 1, 3, 5 and 10 wt.% of graphene |
MSCs did not react toxically to composite robocast scaffolds Cells proliferate and differentiate well on scaffold surfaces | Cartilage tissue engineering | [ |
| Silk fibroin and GO | 0, 0.05, 0.1, 0.2 and 0.4 wt.% of GO | Resulted in better growth capability, proliferation, and osteogenic differentiation of cells. | Bone tissue engineering | [ |
| GO | 3D methacrylated gelatine (GelMA) scaffolds enhanced human MSCs osteogenesis both in vitro and in vivo | Bone regeneration | [ | |
| Gold nanostructure/peptide-nanopatterned GO | Successfully guiding of the human adipose-derived MSCs osteogenesis | Bone regeneration | [ | |
| Polycaprolactone (PCL)/GO | PCL/GO-Dex scaffold enhanced the bone differentiation and MSCs biomineralization responses | Bone tissue engineering | [ | |
| Graphene | Graphene was proved to be: Cytocompatible Osteogenic differentiation inducing Recognized as biomimetic in vitro substrates by human MSCs for osteogenic cell culture experiments | Bone regeneration | [ | |
| GO and rGO | Promoted the cardiomyogenic and angiogenic differentiation capacity of MSCs in vitro | Tissue regeneration | [ | |
| Silica magnetic GO (SMGO) | Improved the hepatoprotective effects of the MSCs derived condition medium on acute liver damage | Cell regeneration | [ | |
| Bacterial cellulose/graphene (BC/G) | Results showed that 3D-BC/G scaffold: Supported NSC growth and adhesion Maintained NSCs stemness and enhanced their proliferative capacity Induced NSCs to selectively differentiate into neurons | Neural tissue engineering | [ | |
| Graphene/poly(dimethylsiloxane) | Significantly promoted the stem cell proliferation | Cell therapy | [ | |
| 3D graphene foams | Produced 3D scaffold suitable for MSCs adhesion, growth, and differentiation into DA neurons | Tissue engineering | [ | |
| GO | GO substrate has potential as a biomaterial for culturing Wharton’s Jelly-MSCs | Stem cell engineering | [ | |
| Gelatine/graphene |
Gelatine conduits’ 3D microstructural and mechanical properties aided MSCs attachment and growth. Electrical stimulation within the 3D gelatine matrix improved differentiation and paracrine activity | Nerve regeneration | [ | |
| Graphene foam (GF)/laminarin hydrogel (LAgel) |
Enhanced scaffold toughness Provided a carrier to realise the biosignals cargo to regulate cell behaviour | Tissue engineering | [ |